Top View
- Genome-Wide Association Study of Leukotriene Modifier Response In
- The Biology of Prostaglandins and Their Role As a Target for Allergic Airway Disease Therapy
- Montelukast and Churg-Strauss Syndrome R Solans, J a Bosch, a Selva, R Orriols, M Vilardell
- Role of Antileukotrienes in Acute Asthma Exacerbations
- (12) (19) STANDARD PATENT AUSTRALIAN PATENT OFFICE (11) Application No. AU 2015296210 B2
- Study Protocol of a Systematic Evidence Update by The
- (12) Patent Application Publication (10) Pub. No.: US 2016/0168090 A1 KARRA (43) Pub
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- A Double-Blind Non-Inferiority Clinical Study of Montelukast, a Cysteinyl
- Amended Clinical Trial Protocol 02
- Step 4: Stick Or Twist? a Review of Asthma Therapy
- Cayman--Eicosanoids.Pdf
- Pharmaabkommen A1 E
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Montelukast, a Leukotriene Receptor Antagonist, for the Treatment of Persistent Asthma in Children Aged 2 to 5 Years
- Customs Tariff - Schedule Xxi - 1
- The Journal of Veterinary Medical Science
- Univeristy of California, San Diego
- ERS Guidelines on the Diagnosis and Treatment of Chronic Cough in Adults and Children
- The Role of Leukotrienes As Potential Therapeutic Targets in Allergic Disorders
- Particle Interactions in Complex Dry Powder Inhaled Formulations and Single Particle Aerosol Mass Spectrometry
- An Emerging Generation of Drug Therapies for Asthma
- Nuclear Translocation of Cysteinyl Leukotriene Receptor 1 Is Involved in Oxygen-Glucose Deprivation- Induced Damage to Endothelial Cells
- The Burden of Allergic Rhinitis: a Mini-Review
- Effects of a Mixture of Ivy Leaf Extract and Coptidis Rhizome on Patients with Chronic Bronchitis and Bronchiectasis
- Airway Inflammation RNA-Induced Enhancement of Allergic Pathway
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Clinical Evaluation of Response to Long-Term Treatment with Pranlukast in Patients with Bronchial Asthma T
- Montelukast Use Over the Past 20 Years: Monitoring of Its Effects And
- Real-Life Effectiveness Evaluation of Asthma Treatment in Korea
- Peters 1.Pdf
- Leukotriene Receptor Antagonists— Monotherapy/Effectiveness Studies
- The Pharmacogenetics and Pharmacogenomics of Asthma Therapy
- Pharmacogenomic Approaches to Asthma Treatment Sang-Heon Cho*
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Pharmacological Treatment of Asthma Today
- G Protein–Coupled Receptors in Asthma Therapy: Pharmacology and Drug Actions
- Lipoxygenase Inhibitors As Potential Cancer Chemopreventives
- (GINA) Pocket Guide 2019
- Effects of Pranlukast Hydrate on Airway Hyperresponsiveness in Non-Asthmatic Patients with Japanese Cedar Pollinosis
- Lipoxygenase Inhibitors As Potential Cancer Chemopreventives
- Investigating and Managing Upper Airway Disorders-Kalayci
- WO 2012/123502 Al 20 September 2012 (20.09.2012) P O P C T
- Center for Drug Evaluation and Research
- Vanderbilt Evidence-Based Practice Center
- Brief Review: Advances in Therapy with Antileukotriene Drugs
- Monoclonal Antibody, Corticosteroid, Leukotriene Modifier, and Bronchodilator